Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

NaPro's paclitaxel approved in Singapore

March 16, 1998

COX-2 inhibitor displays chemopreventive effects in rats

March 13, 1998

Bristol-Myers Squibb and UT Austin announce cancer collaboration

March 12, 1998

Gemzar approved in Canada

March 12, 1998

R.P. Scherer reveals the identity of two more pipeline products

March 12, 1998

New antitumor and immunosuppressive compounds in development at Klinge

March 12, 1998

Antitumor TEPA analogue described by Lithuanian researchers

March 11, 1998

Patient enrollment complete for Gd-Tex phase II trial

March 11, 1998

New melanoma immunotherapy approaches show clinical potential

March 11, 1998

Japanese academics collaborate in the study of oral platinum complex

March 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...